ANIKAnika Therapeutics, Inc.Healthcare · Medical - Devicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $20.84 · now $20.84 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, ANIK has typically landed between $17.09 and $23.53 — a range of −18.0% to +12.9% from the issuance price $20.84.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($20.84) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where ANIK has typically landed a month from the 2026-09-16 close of $20.84 — the range is history, not a prediction.

$17.09worst · -18.0%$23.53best · +12.9%
  • now $20.84 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $20.81 (-0.2%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $19.58–$22.04
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $17.09–$23.53
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2020-02-18−47.2%−47.2%+1.5%
2008-10-23−47.2%−47.2%+9.5%
2008-10-22−44.9%−44.9%+5.5%
3 best
2026-01-28+57.3%+0.0%+57.3%
2026-01-29+56.5%+0.0%+56.9%
2026-01-30+56.0%+0.0%+56.0%

5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
50%
−1.0%
n=20
Feb
65%
+6.3%
n=20
Mar
45%
−1.8%
n=20
Apr
50%
+0.5%
n=20
May
60%
−0.0%
n=20
Jun
45%
+0.8%
n=20
Jul
55%
+5.5%
n=20
Aug
55%
+0.5%
n=20
Sep
55%
+0.5%
n=20
Oct
50%
+0.9%
n=20
Nov
65%
+1.2%
n=20
Dec
40%
−0.2%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$22$82026-08-04: 1 insider purchase, $20K — Fischetti Gary P2026-08-03: 1 insider purchase, $21K — Fischetti Gary P2026-05-01: 1 insider purchase, $73K — HENNEMAN JOHN B III2026-04-30: 1 insider purchase, $150K — Griffin Stephen D.2026-04: 1 open-market purchase, $150K2026-05: 1 open-market purchase, $73K2026-08: 2 open-market purchases, $41K↑ buys↓ salesdirector Fischetti Gary P — Purchase on 2026-08-04, filed 1 day after the tradedirector Fischetti Gary P — Purchase on 2026-08-03, filed 2 days after the tradedirector HENNEMAN JOHN B III — Purchase on 2026-05-01, filed 3 days after the tradedirector Griffin Stephen D. — Purchase on 2026-04-30, filed same day
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-08-04Fischetti Gary PdirectorPurchase1,000 @ $20.32$20K+1.9% of holding+10.7%not yet — horizon still open54,015Form 4 · filed 1 day after the trade
2026-08-03Fischetti Gary PdirectorPurchase1,000 @ $20.75$21K+1.9% of holding+1.2%not yet — horizon still open53,015Form 4 · filed 2 days after the trade
2026-05-01HENNEMAN JOHN B IIIdirectorPurchase5,000 @ $14.66$73K+10.0% of holding−8.6%not yet — horizon still open54,871Form 4 · filed 3 days after the trade
2026-04-30Griffin Stephen D.directorPurchase12,200 @ $12.29$150K+50.9% of holding+12.0%not yet — horizon still open36,163Form 4 · filed same day

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

104 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-06-18Capper Joseph HdirectorAward / grant10,40230,805Form 4
2026-06-18Richard StephendirectorAward / grant10,40258,273Form 4
2026-06-18HENNEMAN JOHN B IIIdirectorAward / grant10,40265,273Form 4
2026-06-18Fischetti Gary PdirectorAward / grant10,40252,015Form 4
2026-06-18CONLEY SHERYL LdirectorAward / grant10,40252,970Form 4
2026-06-03Griffin Stephen D.directorWithheld for tax3,76945,973Form 4
2026-06-03Griffin Stephen D.directorOption exercise12,84012,840Form 4
2026-06-03Griffin Stephen D.directorOption exercise12,84049,742Form 4
2026-06-03Griffin Stephen D.directorOption exercise12,84049,742Form 4
2026-03-19McLeod IanofficerAward / grant11,19411,194Form 4
2026-03-19McLeod IanofficerAward / grant17,66317,663Form 4
2026-03-19McLeod IanofficerAward / grant13,09713,097Form 4
2026-03-15Blanchard Cheryl RdirectorWithheld for tax12,104258,788Form 4
2026-03-15Colleran DavidofficerWithheld for tax1,89367,570Form 4
2026-03-15McLeod IanofficerWithheld for tax78124,107Form 4
2026-03-15McLeod IanofficerOption exercise2,6582,659Form 4
2026-03-15Blanchard Cheryl RdirectorOption exercise25,13125,132Form 4
2026-03-15Colleran DavidofficerOption exercise6,4496,448Form 4
2026-03-15Blanchard Cheryl RdirectorOption exercise25,131270,892Form 4
2026-03-15Colleran DavidofficerOption exercise6,44969,463Form 4
2026-03-15McLeod IanofficerOption exercise2,65824,888Form 4
2026-03-15Colleran DavidofficerOption exercise6,44969,463Form 4
2026-03-15McLeod IanofficerOption exercise2,65824,888Form 4
2026-03-15Blanchard Cheryl RdirectorOption exercise25,131270,892Form 4
2026-03-14Blanchard Cheryl RdirectorWithheld for tax14,728245,761Form 4
2026-03-14Griffin Stephen D.directorWithheld for tax5,94423,963Form 4
2026-03-14Colleran DavidofficerWithheld for tax4,16863,014Form 4
2026-03-14McLeod IanofficerWithheld for tax1,44922,230Form 4
2026-03-14Griffin Stephen D.directorAward / grant6,41229,907Form 4
2026-03-14Blanchard Cheryl RdirectorOption exercise24,51949,040Form 4
2026-03-14McLeod IanofficerAward / grant1,16123,679Form 4
2026-03-14Colleran DavidofficerAward / grant4,69467,182Form 4
2026-03-14Blanchard Cheryl RdirectorAward / grant24,520260,489Form 4
2026-03-14Colleran DavidofficerOption exercise9,38818,777Form 4
2026-03-14Griffin Stephen D.directorOption exercise12,82425,649Form 4
2026-03-14McLeod IanofficerOption exercise3,7747,550Form 4
2026-03-14Blanchard Cheryl RdirectorOption exercise24,519235,969Form 4
2026-03-14McLeod IanofficerOption exercise3,77422,518Form 4
2026-03-14Colleran DavidofficerOption exercise9,38862,488Form 4
2026-03-14Griffin Stephen D.directorOption exercise12,82423,495Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.